Kailo Medical – majority stake sale to Advent Partners

• Kailo Medical (“Kailo”) is a leading Australian provider of structured reporting and interoperability software to the global medical imaging sector
• Its highly regarded product suite helps to standardise radiology reporting and connect imaging systems across providers in 5 geographies, including the USA
• The transaction provides Advent Partners with a scalable, AI-native software platform with beachheads in attractive international markets, with the founders retaining a stake to support the next phase of growth

Industry Context

The transaction reflects sustained appetite from both domestic and offshore private equity for high-quality healthcare software assets, which is driving competitive processes and attractive valuations. Offshore sponsors are increasingly active in Australian-domiciled processes where a long-term US growth angle exists. In the current environment, AI capability has become a threshold topic - investors expect software businesses to demonstrate either defensiveness against emerging AI technologies or a clear path to embedding AI into the product.

Further information on this transaction is available at: AFR Article